Movement Alert｜Core Scientific, Inc. Falls 5.04% in Regular Trading, Post-Upgrade Rally Fades Amid Sector Weakness

Market Focus08-01

On August 1, Core Scientific, Inc. fell 5.04% in regular trading, trading at $20.775/share, with turnover of approximately $190 million.

On the news front, the stock had rallied sharply over the prior two sessions after Keefe, Bruyette & Woods upgraded its rating from Market Perform back to Outperform and raised its price target from $25 to $28. However, the underlying fundamental overhang from Q2 earnings remains unresolved — the company posted a net loss of $3.32 per share, far exceeding the analyst consensus estimate of a $0.06 loss, despite revenue of $164.2 million beating the $144.8 million estimate. Short-term profit-taking following the upgrade-driven bounce pressured shares.

Sector-wide weakness compounded the decline. Within the Application Software sector, AppLovin fell 4.36%, IREN dropped 3.87%, and Strategy declined 4.22%, reflecting broad risk-off sentiment across related names.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1194019033?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-01 03:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194019033","market":"us","top_or_hot":-1,"title":"Movement Alert｜Core Scientific, Inc. Falls 5.04% in Regular Trading, Post-Upgrade Rally Fades Amid Sector Weakness","media":"Market Focus","content":"<p><p>On August 1, Core Scientific, Inc. fell 5.04% in regular trading, trading at $20.775/share, with turnover of approximately $190 million.</p><p>On the news front, the stock had rallied sharply over the prior two sessions after Keefe, Bruyette & Woods upgraded its rating from Market Perform back to Outperform and raised its price target from $25 to $28. However, the underlying fundamental overhang from Q2 earnings remains unresolved — the company posted a net loss of $3.32 per share, far exceeding the analyst consensus estimate of a $0.06 loss, despite revenue of $164.2 million beating the $144.8 million estimate. Short-term profit-taking following the upgrade-driven bounce pressured shares.</p><p>Sector-wide weakness compounded the decline. Within the Application Software sector, AppLovin fell 4.36%, IREN dropped 3.87%, and Strategy declined 4.22%, reflecting broad risk-off sentiment across related names.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Core Scientific, Inc. Falls 5.04% in Regular Trading, Post-Upgrade Rally Fades Amid Sector Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Core Scientific, Inc. Falls 5.04% in Regular Trading, Post-Upgrade Rally Fades Amid Sector Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-01 03:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 1, Core Scientific, Inc. fell 5.04% in regular trading, trading at $20.775/share, with turnover of approximately $190 million.</p><p>On the news front, the stock had rallied sharply over the prior two sessions after Keefe, Bruyette & Woods upgraded its rating from Market Perform back to Outperform and raised its price target from $25 to $28. However, the underlying fundamental overhang from Q2 earnings remains unresolved — the company posted a net loss of $3.32 per share, far exceeding the analyst consensus estimate of a $0.06 loss, despite revenue of $164.2 million beating the $144.8 million estimate. Short-term profit-taking following the upgrade-driven bounce pressured shares.</p><p>Sector-wide weakness compounded the decline. Within the Application Software sector, AppLovin fell 4.36%, IREN dropped 3.87%, and Strategy declined 4.22%, reflecting broad risk-off sentiment across related names.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CORZ","symbol_name":"Core Scientific, Inc.","start_time":0,"source_url":"","article_id":"1194019033","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194019033","pubTimestamp":1785527034,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 1, Core Scientific, Inc. fell 5.04% in regular trading, trading at $20.775/share, with turnover of approximately $190 million.On the news front, the stock had rallied sharply over the prior...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CORZ":"Core Scientific, Inc."},"translate_title":"走势警报|Core Scientific, Inc. 常规交易中下跌 5.04%，升级后涨势因行业疲软而消退","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CORZ":1},"content_text":"On August 1, Core Scientific, Inc. fell 5.04% in regular trading, trading at $20.775/share, with turnover of approximately $190 million.On the news front, the stock had rallied sharply over the prior two sessions after Keefe, Bruyette & Woods upgraded its rating from Market Perform back to Outperform and raised its price target from $25 to $28. However, the underlying fundamental overhang from Q2 earnings remains unresolved — the company posted a net loss of $3.32 per share, far exceeding the analyst consensus estimate of a $0.06 loss, despite revenue of $164.2 million beating the $144.8 million estimate. Short-term profit-taking following the upgrade-driven bounce pressured shares.Sector-wide weakness compounded the decline. Within the Application Software sector, AppLovin fell 4.36%, IREN dropped 3.87%, and Strategy declined 4.22%, reflecting broad risk-off sentiment across related names.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1194019033","isCrawlerRequest":true}